Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul;190(1):e9-e11.
doi: 10.1111/bjh.16787. Epub 2020 May 18.

Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma

Affiliations

Interleukin 6-blockade treatment for severe COVID-19 in two patients with multiple myeloma

Aristeidis Chaidos et al. Br J Haematol. 2020 Jul.
No abstract available

Keywords: COVID-19; cytokine release syndrome; interleukin-6; myeloma; tocilizumab.

PubMed Disclaimer

References

    1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med.2020 [Epub ahead of print]. https://doi.org/10.1056/NEJMoa2002032.
    1. Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. Nati Sci Rev. 2020 [Epub ahead of print]. https://doi.org/10.1093/nsr/nwaa041.
    1. Castilletti C, Bordi L, Lalle E, Rozera G, Poccia F, Agrati C, et al. Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication. Virology. 2005;341:163-9.
    1. Tseng CT, Perrone LA, Zhu H, Makino S, Peters CJ. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. J Immunol. 2005;174:7977-85.
    1. Moore BJB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368:473-4.

LinkOut - more resources